RPG Life Sciences standalone net profit declines 83.76% in the September 2024 quarter

Net profit of RPG Life Sciences declined 83.76% to Rs 4.20 crore in the quarter ended September 2024 as against Rs 25.86 crore during the previous quarter ended September 2023. Sales rose 12.13% to Rs 172.21 crore in the quarter ended September 2024 as against Rs 153.58 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	172.21	153.58	12
OPM %	26.67	24.28	-
PBDT	47.70	39.02	22
PBT	42.39	34.79	22
NP	4.20	25.86	-84